Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

NCT00295035 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Colon Neoplasm

Interventions

DRUG: CELECOXIB
DRUG: CURCUMIN

Sponsor

Tel-Aviv Sourasky Medical Center